title: Severity as an independent determinant of the social value of a health service.
abstract: This paper has two objectives, first to review the relevant literature concerning the social importance of severity of pre-treatment condition, and second to present the results of a new analysis of the relationship between social value, individual assessment of health improvement and the severity of illness. The present study differs methodologically from others reported in the literature. The underlying hypothesis is that members of the public have an aversion to patients being in a severe health state irrespective of the reason for their being there, and that this aversion will affect the social valuation of a health program after taking account of the magnitude of the health improvement. This effect will be observable in a program which (compared to another) takes a person out of a severe health state--the usual case discussed in the literature--or in a program which (compared to another) leaves a person in a severe health state. The present study tests this second implication of the hypothesis. We present data consistent with the view that after taking account of health improvement, health programs are preferred which do not leave people in severe health states. Alternative explanations are considered and particularly the possibility that data reflect a social preference for individuals achieving their health potential. Both explanations imply the need to reconsider the rules for prioritizing programs. In this analysis, Person Trade-Off (PTO) scores are used to measure social preferences ('value' or 'social utility') and Time Trade-Off (TTO) scores are used to measure individual assessments of health improvement and initial severity. Econometric results suggest that severity is highly significant and may more than double the index of social value of a health service.
authors.affiliation: Centre for Health Economics, Monash University, Clayton, VIC, 3800, Australia. jeff.richardson@buseco.monash.edu.au
authors.forename: Jeff R J
authors.initials: JR
authors.lastname: Richardson
authors.forename: John
authors.initials: J
authors.lastname: McKie
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Peacock
authors.forename: Angelo
authors.initials: A
authors.lastname: Iezzi
mesh_terms: D000328:Adult; D003362:Cost-Benefit Analysis; D005260:Female; D006296:Health Services / Q000706:statistics & numerical data*; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D057240:Patient Preference / Q000523:psychology*; D011788:Quality of Life / Q000523:psychology*; D057566:Self Report; D012720:Severity of Illness Index; D012945:Social Values; D012959:Socioeconomic Factors
references.citation: Bioethics. 1993 Apr;7(2-3):224-33
references.pmid: 11651535
references.citation: Health Econ. 1999 Feb;8(1):25-39
references.pmid: 10082141
references.citation: Int J Technol Assess Health Care. 1993 Fall;9(4):463-78
references.pmid: 8288424
references.citation: Int J Health Plann Manage. 1991 Jul-Sep;6(3):234-42
references.pmid: 10116626
references.citation: J Health Econ. 2006 Jan;25(1):170-2; discussion 173-4
references.pmid: 16213617
references.citation: Health Econ. 2004 Feb;13(2):171-81
references.pmid: 14737754
references.citation: Milbank Q. 1994;72(3):451-70
references.pmid: 7935242
references.citation: Med Decis Making. 1996 Apr-Jun;16(2):108-16
references.pmid: 8778528
references.citation: J R Coll Physicians Lond. 1992 Oct;26(4):390-2
references.pmid: 1432881
references.citation: Expert Rev Pharmacoecon Outcomes Res. 2001 Oct;1(1):85-92
references.pmid: 19807511
references.citation: Health Econ. 1998 Jun;7(4):307-12
references.pmid: 9683091
references.citation: Soc Sci Med. 1995 Nov;41(10):1429-37
references.pmid: 8560311
references.citation: J Health Econ. 2005 Jul;24(4):703-14
references.pmid: 15960992
references.citation: Health Policy. 2002 Aug;61(2):189-99
references.pmid: 12088891
references.citation: Med Decis Making. 1998 Apr-Jun;18(2):141-8
references.pmid: 9566447
references.citation: Ann Med. 2001 Jul;33(5):371-4
references.pmid: 11491196
references.citation: Transplant Proc. 1989 Jun;21(3):3437-9; discussion 3440-4
references.pmid: 2741209
references.citation: Med Decis Making. 1995 Jul-Sep;15(3):287-8
references.pmid: 7564944
references.citation: Health Econ. 1997 Jan-Feb;6(1):71-81
references.pmid: 9142532
references.citation: Health Policy. 1993 Aug;24(3):227-38
references.pmid: 10128127
references.citation: J Health Econ. 2007 Jul 1;26(4):785-99
references.pmid: 17328979
references.citation: J Med Ethics. 1987 Sep;13(3):117-23
references.pmid: 3669036
references.citation: J Med Ethics. 1993 Mar;19(1):37-42
references.pmid: 8459438
references.citation: Soc Sci Med. 1999 Oct;49(7):895-903
references.pmid: 10468394
references.citation: Health Econ. 1999 Dec;8(8):701-7
references.pmid: 10590471
references.citation: JAMA. 1993 Nov 24;270(20):2469-74
references.pmid: 8230624
references.citation: Health Policy. 2000 Feb;51(1):19-30
references.pmid: 11010223
references.citation: Health Econ. 2010 May;19(5):596-607
references.pmid: 19459186